Farsightedness or Hyperopia is a common form of visual imparment. When the eye recieves an image it focuses this behind the eye rather than on the back of the eye. Strong glasses or contact lenses are required to help bring the rays upstream to focus on the retina.

Farsighted individuals typically have excellent vision when young but find they need glasses to read in their 30’s and eventually need glasses for all activities. Correction options include:

  • Laser eye surgery
  • Implantable Contact Lenses
  • Laser Lens Replacement
Farsighted Eye Illustration

Correcting Hyperopia

If the cornea is flat, then IntraLASIK with the Zyoptix Wavefront algorithm is a good option for correction. Plus 5.00 Dioptres and in selected cases more can be treated and the advantage of the Wavefront treatment is the ability to create wide zones with less tissue removal – bespoke and personalised for the individual eye.

A word about Presbyopia

If you are over 42 and your near sight is gradually being lost and you require READING GLASSES, it is probably caused by increasing hardness of the lens in your eye – the lens can no longer change shape enough to focus. Supracor IntraLASIK can now be used to treat Presbyopia correcting vision at all distances.

For those over 50, a good option for vision correction is Laser Lens Exchange also known as Lens Replacement surgery with implantation of high performance Trifocal lens implants.

There are a number of other criteria that a suitable candidate requires

  • Healthy eyes with no disease
  • No abnormalities in corneal shape (e.g. keratoconus)
  • Prescription within the range of correction
  • Do not have a profoundly lazy eye (amblyopia)
  • Are not pregnant or nursing
  • Are in good general health

There are a number of options available to treat farsightedness, but they generally fall into 3 categories.

  • Laser Eye Surgery
  • Laser Lens Replacement
  • Implantable Contact Lenses

Author Information

Authored by Sheraz Daya MD FACP FACS FRCS(Ed) FRCOphth, Consultant Ophthalmic Surgeon & Medical Director, June 2019.

Next review due June 2020.